Combination of Tamoxifen and rIFN-β in MPN? Tamoxifen, a selective estrogen receptor (ER) modulator, has been used for decades in the treatment and prevention of estrogen-positive breast cancer [183]. Here, ESR1 is linked to myeloproliferative neoplasm.